1. Home
  2. CKPT vs ISSC Comparison

CKPT vs ISSC Comparison

Compare CKPT & ISSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CKPT
  • ISSC
  • Stock Information
  • Founded
  • CKPT 2014
  • ISSC 1988
  • Country
  • CKPT United States
  • ISSC United States
  • Employees
  • CKPT N/A
  • ISSC N/A
  • Industry
  • CKPT Biotechnology: Pharmaceutical Preparations
  • ISSC EDP Services
  • Sector
  • CKPT Health Care
  • ISSC Technology
  • Exchange
  • CKPT Nasdaq
  • ISSC Nasdaq
  • Market Cap
  • CKPT 172.4M
  • ISSC 186.8M
  • IPO Year
  • CKPT 2017
  • ISSC 2000
  • Fundamental
  • Price
  • CKPT $3.13
  • ISSC $7.92
  • Analyst Decision
  • CKPT Strong Buy
  • ISSC
  • Analyst Count
  • CKPT 3
  • ISSC 0
  • Target Price
  • CKPT $12.00
  • ISSC N/A
  • AVG Volume (30 Days)
  • CKPT 753.4K
  • ISSC 308.4K
  • Earning Date
  • CKPT 03-21-2025
  • ISSC 02-13-2025
  • Dividend Yield
  • CKPT N/A
  • ISSC N/A
  • EPS Growth
  • CKPT N/A
  • ISSC 3.71
  • EPS
  • CKPT N/A
  • ISSC 0.38
  • Revenue
  • CKPT $47,000.00
  • ISSC $53,858,686.00
  • Revenue This Year
  • CKPT N/A
  • ISSC $28.37
  • Revenue Next Year
  • CKPT $300,658.78
  • ISSC $11.93
  • P/E Ratio
  • CKPT N/A
  • ISSC $20.86
  • Revenue Growth
  • CKPT N/A
  • ISSC 43.24
  • 52 Week Low
  • CKPT $1.38
  • ISSC $4.91
  • 52 Week High
  • CKPT $4.50
  • ISSC $12.17
  • Technical
  • Relative Strength Index (RSI)
  • CKPT 46.36
  • ISSC 31.12
  • Support Level
  • CKPT $3.10
  • ISSC $7.77
  • Resistance Level
  • CKPT $3.43
  • ISSC $8.61
  • Average True Range (ATR)
  • CKPT 0.26
  • ISSC 0.59
  • MACD
  • CKPT 0.00
  • ISSC -0.47
  • Stochastic Oscillator
  • CKPT 33.03
  • ISSC 3.61

About CKPT Checkpoint Therapeutics Inc.

Checkpoint Therapeutics Inc is an immuno-oncology biopharmaceutical company based in the USA. It focuses on the acquisition, development, and commercialization of novel, non-chemotherapy, immune-enhanced combination treatments for patients with solid tumor cancers. Its licensed portfolio of antibodies includes targeting programmed cell death-ligand 1 (PD-L1), glucocorticoid-induced TNFR-related protein (GITR) and carbonic anhydrase IX (CAIX). The company is evaluating its lead small-molecule, targeted anti-cancer agent, olafertinib, a third-generation epidermal growth factor receptor ("EGFR") inhibitor, as a potential new treatment for patients with EGFR mutation-positive non-small cell lung cancer.

About ISSC Innovative Solutions and Support Inc.

Innovative Solutions and Support Inc is a systems integrator that designs, manufactures, sells, and services air data equipment, engine display systems, standby equipment, primary flight guidance, and cockpit display systems for retrofit applications and original equipment manufacturers. The company supplies integrated Flight Management Systems, Flat Panel Display Systems, Integrated Standby Units, Positioning System receivers that enable reduced carbon footprint navigation, and an Autothrottle, which allows a pilot to automatically control the power setting of the engine and is designed to reduce pilot workload and enhance safety. It sells its products to both the OEM and the retrofit markets.

Share on Social Networks: